Skip to the page

Data / Drug companies / Mayne Pharma Inc.

Mayne Pharma Inc.: 34 products in the FDA NDC directory, labeler code 51862

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Mayne Pharma Inc. (labeler code 51862) lists 34 products in the FDA National Drug Code Directory, covering 26 finished drugs by generic name. By type: 34 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 8, 2025.

The request: Watch Mayne Pharma Inc. (FDA labeler code 51862): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51862
Products in commercial distribution
34
Packages
62
Finished drugs by generic name
26
Prescription products
34
Over the counter products
0
Flagged as original packager
34 of 34 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
1
Earliest marketing start
June 1, 2016
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)2470.6%
New drug applications (NDA)1029.4%

Products by type

TypeProductsShare
Prescription drugs34100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Kit1750%
Cream411.8%
Aerosol, foam411.8%
Capsule12.9%
Patch, extended release12.9%
Tablet, delayed release12.9%
Capsule, gelatin coated12.9%
Liquid12.9%
Solution12.9%
Gel12.9%
Tablet, film coated12.9%
Tablet12.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Lexette51862-618Aerosol, foamGeneric drugs (ANDA)August 8, 2025
Epsolay51862-772CreamNew drug applications (NDA)August 1, 2025
Twyneo51862-771CreamNew drug applications (NDA)August 1, 2025
Rhofade51862-765CreamNew drug applications (NDA)October 24, 2024
Dapsone51862-123GelGeneric drugs (ANDA)February 14, 2024
Doryx mpc51862-560Tablet, delayed releaseNew drug applications (NDA)January 2, 2023
Tamoxifen Citrate51862-643Tablet, film coatedGeneric drugs (ANDA)August 27, 2021
Soltamox51862-682LiquidNew drug applications (NDA)June 18, 2021
Nextstellis51862-258KitNew drug applications (NDA)April 16, 2021
Calcipotriene51862-512Aerosol, foamNew drug applications (NDA)February 15, 2021
Tavaborole51862-690SolutionGeneric drugs (ANDA)February 1, 2021
Tri-Nymyo51862-646KitGeneric drugs (ANDA)October 24, 2020
Zovia 1/3551862-894KitGeneric drugs (ANDA)October 16, 2020
Tilia Fe51862-896KitGeneric drugs (ANDA)October 15, 2020
Necon51862-892KitGeneric drugs (ANDA)October 12, 2020
Microgestin Fe 1.5/3051862-870KitGeneric drugs (ANDA)October 12, 2020
Microgestin 1/2051862-868KitGeneric drugs (ANDA)October 12, 2020
Microgestin Fe 1/2051862-866KitGeneric drugs (ANDA)October 12, 2020
Microgestin 24 Fe51862-648KitGeneric drugs (ANDA)October 12, 2020
Microgestin 1.5/3051862-872KitGeneric drugs (ANDA)October 11, 2020
Nymyo51862-645KitGeneric drugs (ANDA)October 11, 2020
Desogestrel and Ethinyl Estradiol51862-514KitGeneric drugs (ANDA)October 4, 2020
Azurette51862-890KitGeneric drugs (ANDA)October 3, 2020
Chlorzoxazone51862-339TabletGeneric drugs (ANDA)July 31, 2020
Fluorouracil51862-362CreamGeneric drugs (ANDA)December 3, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.